Chemistry:Cannabimovone: Difference between revisions
From HandWiki
(update) |
(No difference)
|
Latest revision as of 15:06, 19 November 2022
Short description: Chemical compound
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C21H30O4 |
| Molar mass | 346.467 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cannabimovone (CBM) is a phytocannabinoid first isolated from a non-psychoactive strain of Cannabis sativa in 2010, which is thought to be a rearrangement product of cannabidiol. It lacks affinity for cannabinoid receptors, but acts as an agonist at both TRPV1 and PPARγ.[1][2][3][4]
See also
- Cannabichromene
- Cannabicitran
- Cannabicyclol
- Cannabielsoin
- Cannabigerol
- Cannabinodiol
- Cannabitriol
- Delta-6-CBD
References
- ↑ "Cannabimovone, a Cannabinoid with a Rearranged Terpenoid Skeleton from Hemp.". European Journal of Organic Chemistry 2010 (11): 2067–2072. 2010. doi:10.1002/ejoc.200901464.
- ↑ "Synthesis of (-)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization". Angewandte Chemie 55 (25): 7121–5. June 2016. doi:10.1002/anie.201601834. PMID 27119910.
- ↑ "An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol". Frontiers in Pharmacology 8: 422. 2017. doi:10.3389/fphar.2017.00422. PMID 28701957.
- ↑ "Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study". Molecules (Basel, Switzerland) 25 (5): 1119. March 2020. doi:10.3390/molecules25051119. PMID 32138197.
 |  |
